Key result
Levosimendan appears suitable for preoperative cardiac optimization in HF patients undergoing major elective surgery.
Why the study?
Does levosimendan improve perioperative outcomes in patients with heart failure undergoing major elective non-cardiac surgery?
Does levosimendan improve perioperative outcomes in patients with heart failure undergoing major elective non-cardiac surgery?
Levosimendan appears to be a theoretically suitable agent for preoperative optimization of cardiac function in heart failure patients undergoing major elective non-cardiac surgery, though large-scale trials are required.
No takes yet. Share an insight, caveat, or question.
May support levosimendan for preoperative HF optimization; hypothesis-generating pending large RCTs.
Morelli et al. (2009) conducted a review in Heart failure undergoing non-cardiac surgery. Levosimendan was evaluated. Levosimendan appears to be a suitable agent for preoperative optimization of cardiac function in heart failure patients undergoing major elective surgery, though large-scale trials are needed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: